Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 430 of 1,261
  1. US 10619156

    Hybrid tRNA/pre-miRNA molecules and methods of use

    The Regents of the University of California · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  2. US 10618869

    Oligo-benzamide compounds and their use

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  3. US 10617136

    Calcium oxide compound with high purity

    ARKIM KIMYEVI MADDELER SANAYI VE TICARET ANONIM SIRKETI · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  4. US 10618908

    Oxabicycloheptane prodrugs

    Lixte Biotechnology, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  5. US 10617737

    Compositions for treating heart disease by inhibiting the action of mAKAP-β

    Anchored RSK3 Inhibitors, LLC · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  6. US 10617723

    C. novyi for the treatment of solid tumors in humans

    Biomed Valley Discoveries, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  7. US 10617747

    Peptide conjugated particles

    Northwestern University · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  8. US 10617740

    Methods of treating mild brain injury

    The Regents of the University of California · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  9. US 10619157

    Cancer treatment

    Ionis Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  10. US 10617663

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  11. US 10617642

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  12. US 10617707

    Oligonucleotides to treat eye disease

    ProQR Therapeutics II B.V. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  13. US 10617674

    Dosage regimen for the treatment of acute exacerbations of inflammatory conditions

    MEREO BIOPHARMA 1 LIMITED · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  14. US 10617706

    Compounds for cancer chemotherapeutic sensitization

    Regents of the University of Minnesota · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  15. US 10617681

    1-arylalkyl-4-acylaminopiperidine compounds

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  16. US 10619160

    Compositions and methods for inhibiting expression of RRM2 genes

    Arrowhead Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  17. US 10619158

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  18. US 10618972

    Antibodies for botulinum neurotoxins

    The Regents of the University of California · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  19. EP 3630112

    KOMBINATION AUS REGORAFENIB UND PD-1/PD-L1(2)-INHIBITOREN ZUR BEHANDLUNG VON KREBS

    BAYER AG [DE] · Granted Apr 8, 2020 · Expires Apr 3, 2040

    granted
  20. US 10610534

    Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

    Corcept Therapeutics Incorporated · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  21. US 10610520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  22. US 10611845

    Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  23. US 10611771

    Pyrazolo [3,4-d] pyrimidine derivative

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  24. US 10610601

    Polymeric antibiotics

    The Regents of the University of California · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.